{"nct_id":"NCT04437511","title":"A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-08","start_date":"2020-06-19","start_date_type":"ACTUAL","primary_completion_date":"2023-04-14","primary_completion_date_type":"ACTUAL","completion_date":"2028-11","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["LLY"]}